Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy

OBJECTIVES: This post hoc analysis assessed speed, magnitude and maintenance of pain improvement in patients with early rheumatoid arthritis (RA) receiving baricitinib, baricitinib and methotrexate (MTX), or MTX over 1 year. Cumulative pain and quality of life benefits were also assessed. METHODS: R...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Peter C., Alten, Rieke, Álvaro Gracia, Jose María, Kaneko, Yuko, Walls, Chad, Quebe, Amanda, Jia, Bochao, Bello, Natalia, Terres, Jorge Ross, Fleischmann, Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915362/
https://www.ncbi.nlm.nih.gov/pubmed/35264432
http://dx.doi.org/10.1136/rmdopen-2021-001994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915362/
https://www.ncbi.nlm.nih.gov/pubmed/35264432
http://dx.doi.org/10.1136/rmdopen-2021-001994

Ejemplares similares